CompletedNCT00136760
Bupropion and vouchers to support smoking cessation in schizophrenia
About this title
Read the official source — NCT00136760Medication studyAges 18–80United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 80 years.
- Listed locations
- ProvidenceSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateSeptember 2003
- Recruitment status
- Completed
- Enrollment listed in the registry
- 57
- Sponsor
- Brown University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 80 Years
- Official registry ID
- NCT00136760
- Official title
Show the full official title
Incentives Plus Bupropion for Smoking in Schizophrenics
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Providence
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Brown University, a university.
Did this study involve medication?
Yes. The study involved medication, including Bupropion, Contingent reinforcement plus placebo, non-contingent reinforcement plus bupropion and Non-contingent reinforcement plus placebo.
Who was this study for?
Listed age limits: 18 years to 80 years.
